tetano
Editor, Senior Moderator
J Pediatric Infect Dis Soc
. 2022 Sep 5;piac099.
doi: 10.1093/jpids/piac099. Online ahead of print.
"Race, ethnicity, and health disparities in US children with COVID-19: a review of the evidence and recommendations for the future"
Claudia P Vicetti Miguel[SUP] 1 [/SUP], Shom Dasgupta-Tsinikas[SUP] 2 [/SUP], Gabriella S Lamb[SUP] 3 [/SUP], Liset Olarte[SUP] 4 [/SUP], Roberto P Santos[SUP] 5 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19) is an important cause of morbidity in children in the United States (U.S.). Moreover, the U.S. has witnessed significant disparities affecting American Indian/Alaska Native, Black, and Hispanic/Latino children, stemming from systemic racism and social-structural inequalities and not differences in innate biological susceptibility. We review what is known on COVID-19 and health disparities in disease burden, access to care, pharmaceutical interventions, and clinical research in children, with a focus on the U.S. context. In addition, we propose strategies to communicate scientific data in ways that do not promote racism and biological susceptibility themes, and to address pediatric disparities in clinical infectious diseases research.
. 2022 Sep 5;piac099.
doi: 10.1093/jpids/piac099. Online ahead of print.
"Race, ethnicity, and health disparities in US children with COVID-19: a review of the evidence and recommendations for the future"
Claudia P Vicetti Miguel[SUP] 1 [/SUP], Shom Dasgupta-Tsinikas[SUP] 2 [/SUP], Gabriella S Lamb[SUP] 3 [/SUP], Liset Olarte[SUP] 4 [/SUP], Roberto P Santos[SUP] 5 [/SUP]
Affiliations
- PMID: 36063366
- DOI: 10.1093/jpids/piac099
Abstract
Coronavirus disease 2019 (COVID-19) is an important cause of morbidity in children in the United States (U.S.). Moreover, the U.S. has witnessed significant disparities affecting American Indian/Alaska Native, Black, and Hispanic/Latino children, stemming from systemic racism and social-structural inequalities and not differences in innate biological susceptibility. We review what is known on COVID-19 and health disparities in disease burden, access to care, pharmaceutical interventions, and clinical research in children, with a focus on the U.S. context. In addition, we propose strategies to communicate scientific data in ways that do not promote racism and biological susceptibility themes, and to address pediatric disparities in clinical infectious diseases research.